Diane L. DeHaven‐Hudkins

Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain

Diane L. DeHaven‐Hudkins, Lorraine C. Fleissner, Felicia Y. Ford-Rice · European Journal of Pharmacology Molecular Pharmacology · 1992 · 177 citations

Synaptic Transmission, Neurotransmitter, Neurotransmission +16

Loperamide (ADL 2-1294), an Opioid Antihyperalgesic Agent with Peripheral Selectivity

Diane L. DeHaven‐Hudkins, Luz Cortes Burgos, Joel Cassel et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 145 citations

Potent, Orally Bioavailable Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of<i>N</i>,<i>N</i>-Diethyl-4-(5-hydroxyspiro[chromene-2,4′-piperidine]-4-yl)benzamide (ADL5859)

Bertrand Le Bourdonnec, Rolf T. Windh, Christopher W. Ajello et al. · Journal of Medicinal Chemistry · 2008 · 89 citations · Full text

Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of<i>N</i>,<i>N</i>-Diethyl-3-hydroxy-4-(spiro[chromene-2,4′-piperidine]-4-yl) Benzamide (ADL5747)

Bertrand Le Bourdonnec, Rolf T. Windh, Lara K. Leister et al. · Journal of Medicinal Chemistry · 2009 · 83 citations · Full text

The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease

James B. Koprich, Susan H. Fox, Tom H. Johnston et al. · Movement Disorders · 2011 · 68 citations